Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Arginine Vasopressin DeficiencyCentral Diabetes InsipidusOxytocin Deficiency

Interventions

DRUG

Oxytocin nasal spray

24 IU

DRUG

Placebo

0.9% NaCl

Trial Locations (1)

RECRUITING

University Hospital Basel, Basel

All Listed Sponsors

lead

University Hospital, Basel, Switzerland

OTHER